We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Privacy Terms and Cookie Policy
<p>Balanced Reporting. Trusted Insights.</p>
Tuesday, April 01, 2025
In this opinion piece, Dana M. O’Brien, president and founder of BioHarbor Strategies, says the new Congress and incoming Trump administration must support and accelerate biomanufacturing as a national policy priority.
Dana O'Brien stresses the need for Congress and the White House to pass One Health strategies and modernize America’s animal biotechnology regulatory approach with everything going on with COVID-19; two policies that are long overdue.
Dana O’Brien is the executive vice president of food & agriculture at Biotechnology Innovation Organization (BIO) and in this piece he shares his thoughts on improving the regulatory system for animal biotechnology.
.png?height=300&t=1727107145&width=400 "Dana O'Brien")
